NCT02304757View on ClinicalTrials.gov

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Differentiated Thyroid CancerOsteoporosis
Interventions
DRUG

99Tc-MDP

99Tc-MDP, H20000218

DRUG

Fosamax

H20080172

Trial Locations (1)

200092

Nuclear Medicine Xinhua Hospital, Shanghai

All Listed Sponsors
lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

NCT02304757 - 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis | Biotech Hunter | Biotech Hunter